MIN-102

· Minoryx Therapeutics, S.L.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MIN-102, covering 2022-10-13 to 2025-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients. [Phase 2, Phase 3]